DrugJul 1, 2026
METHYLERGONOVINE MALEATE Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg recall — FDA D-0609-2026
Subpotent Drug
Class IIFDA: OngoingThe Harvard Drug Group LLC
Recall history in this database
Classification mix: Class II: 4.
DrugApr 29, 2026
OMEGA-3-ACID ETHYL ESTERS Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules recall — FDA D-0493-2026
Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
Class IIFDA: OngoingThe Harvard Drug Group LLC
DrugOct 29, 2025
Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack) recall — FDA D-0031-2026
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
Class IIFDA: OngoingThe Harvard Drug Group LLC
DrugOct 29, 2025
Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs) recall — FDA D-0030-2026
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
Class IIFDA: OngoingThe Harvard Drug Group LLC
Understanding this recall history
This page summarizes recall records in which the official source identifies The Harvard Drug Group LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.